PRFX News and Press, PainReform Ltd. From 11/23/21

Gainers: Pasithea Therapeutics (NASDAQ:KTTA) +257%, Petros Pharmaceuticals (NASDAQ:PTPI) +73%, Gracell Biotechnologies (NASDAQ:GRCL) +64%, iSpecimen (NASDAQ:ISPC) +43%, Qualigen Therapeutics (NASDAQ:QLGN) +33%. Losers: Longeveron (NASDAQ:LGVN) -36%...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurinia Pharma (NASDAQ: AUPH ) stock is taking a beating on Monday following a filing with the U.S. Securities and Exchange Commission (SEC) on Friday. Source: Bukhta Yurii / Shutterstock.com Let’s jump...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rivian (NASDAQ: RIVN ) stock is in the news today thanks to talk from Outdoorsy about a potential deal for electric vehicles (EVs). Source: Miro Vrlik Photography / Shutterstock.com Let’s take a look ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PainReform (NASDAQ: PRFX ) stock is on the move Monday with heavy trading despite a lack of news coming from the medical device company. Source: Shutterstock Instead, it looks like traders on social media ha...

Astra Space (NASDAQ:ASTR) +35% after successful commercial orbital launch iSpecimen (NASDAQ:ISPC) +26% selected by U.S. Government and private researchers to supply critical human biospecimens for advanced phase of COVID-19 research PainReform (NASDAQ:PRFX) +19%. Vonage Holding...

Gainers:Greenland Technologies Holding (NASDAQ:GTEC) +72%. Longeveron LGVN +51%. Aurora Innovation AUR +30%. UWM Holdings Corporation UWMC +16%. PainReform  (NASDAQ:PRFX) +16%. Losers: Connect Biopharma Holdings CNTB -56%. ReTo Eco-Solutions (NASDAQ:RETO) -42%. F...

PainReform (NASDAQ:PRFX): Q3 Net Loss of %5.5M Cash and cash equivalents of $18.4M Shares -1.57% PM. Press Release For further details see: PainReform reports Q3 results

Reports continued progress towards commencing Phase 3 clinical trials Announces Selection of Pharmaceutics International, Inc . as U.S. Manufacturer of PRF-110 for Upcoming Phase 3 Trial TEL AVIV, Israel, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Pain...

TEL AVIV, Israel, Oct. 14, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of Pai...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...